Are California Hospital Systems Rapidly Increasing Prices? The Data Suggest Not All Systems Are Alike
Average price growth was high among California for-profit systems (31% over the study period), while non-profit and public systems had lower average price growth (13%) than nonsystem hospitals (15%).
Interdisciplinary Panel Offers Solutions to Improve Recruitment for Alzheimer’s Clinical Trials
Experts from the private and public sectors convened a panel to improve recruitment for Alzheimer’s clinical trials.
Efforts to Save Money on Prescription Drugs Associated with Increased Stroke Risk for Seniors
Tools used by insurers and PBMs to contain costs result in fewer patients using NOACs or warfarin
Largest Medicare Advantage Plans Pay Big Markups for Dialysis
Large dialysis chains charge Medicare Advantage plans 27% more than the traditional, fee-for-service Medicare program.
Risk for Heart Attack, Stroke or Death Can Double or Triple in Older Adults Concurrently Taking Multiple Medications with Cardiovascular Side Effects
Using multiple medications with known cardiovascular adverse effects at the same time substantially increases cardiovascular risk.
Benzodiazepines Don’t Increase Dementia Risks in Older Adults, USC Study Finds
There is little evidence that older adults prescribed benzodiazepines are at increased risk of developing dementia.
Cannabis Regulations Inadequate Given Rising Health Risks of High-Potency Products
A new USC Schaeffer Center white paper shows how state-level cannabis regulations have weak public health parameters compared to other countries, leaving consumers vulnerable.
Surprise Billing Dispute Resolution Outcomes in Texas Anchored to Median In-Network Allowed Amount
Analysis of cases that went through dispute resolution found the final allowed were largely anchored to the established.
Interdisciplinary Hub Fosters Innovative Solutions for Improving Diversity in Clinical Trials
USC has received $5.8 million from Gates Ventures and the American Heart Association to launch a lab aimed at diversifying clinical trials.
Schaeffer White Paper Highlights Failures in Generic Drug Market That Cost Patients
A new USC Schaeffer Center paper highlights tactics used by intermediaries in the pharmaceutical distribution system, including pharmacy benefit managers (PBMs) and insurers, that are costing patients, employers and the government billions for what should be inexpensive medicines.